Amycretin vs Liraglutide

Amycretin is an experimental drug that combines two hormone signals (amylin and GLP-1) to help control blood sugar and appetite, but it is not yet approved by the FDA for any use. Liraglutide, sold as Saxenda or Victoza, is an FDA-approved GLP-1 drug used to treat type 2 diabetes, obesity, and reduce cardiovascular risk; it is taken as a daily injection.

AI summary of the sources below.